#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuromyelitis optica spectrum disorder Noonan syndrome Pouchitis Meningitis meningococcal Gastrointestinal cancer metastatic Haemophilia B without inhibitors Wiskott-Aldrich syndrome Polycystic liver disease Central nervous system lymphoma IgA nephropathy Transferrin decreased Neonatal asphyxia Small cell lung cancer Leiomyosarcoma Mantle cell lymphoma stage IV More trials…

    Learn about Rare Diseases

    Combined immunodeficiency Myelodysplastic syndrome Advanced systemic mastocytosis – Treatment Familial haemophagocytic lymphohistiocytosis – Treatment Biotinidase deficiency – Trials in Disease Medulloblastoma – Diagnostics Burkitt’s lymphoma – Basic Information Acute respiratory distress syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Diagnostics Alternating hemiplegia of childhood – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Heterodimeric Interleukin-15 Goserelin Arginine Hydrochloride GXV813 LIGUFALIMAB SGN-ALPV Soya-Bean Oil Refined Belimumab Topotecan Tamsulosin Hydrochloride Alisertib Sodium Bisoprolol Fumarate Migalastat Rugonersen Linrodostat Mesilate Levocabastine Hydrochloride Danicamtiv Medi0618 Piperacillin Sodium Corylus Avellana L. More therapies…

    Learn about Your Condition

    Colorectal adenocarcinoma Haemorrhage intracranial Diarrhoea Uveitis Pyoderma HIV infection Chronic disease Breast cancer female Ventricular extrasystoles Breast cancer stage II Metabolic disorder Behavioural addiction Tuberculosis Uterine cancer Pancoast's tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Aortic valve stenosis

  • Study on Icosapent Ethyl for Slowing Aortic Valve Stenosis Progression in Patients with Aortic Valve Stenosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Icosapent Ethyl
    The Netherlands

  • Study on Short vs. Long Antiplatelet Therapy with Aspirin for Adults After TAVI for Symptomatic Aortic Stenosis

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • D,L-Lysine Acetylsalicylate
    • Acetylsalicylic Acid
    France

  • Study on Pelacarsen for Slowing Calcific Aortic Valve Stenosis in Patients

    Recruiting

    2 1
    Investigated Drugs:
    • Pelacarsen
    Austria Belgium Czechia Denmark France Germany +4

  • Study on Personalized Antithrombotic Therapy with Acenocoumarol, Phenprocoumon, and Apixaban for Patients with Aortic Valve Stenosis Post-TAVI

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Investigated Drugs:
    • Acenocoumarol
    • D,L-Lysine Acetylsalicylate
    • Prasugrel
    Belgium Denmark France Germany The Netherlands

  • A Phase 2b/3 Randomized Double‑Blind Study of Ataciguat to Slow Disease Progression in Adults with Moderate Calcific Aortic Valve Stenosis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Aortic valve stenosis
    Austria Czechia France Norway Poland Portugal +1

  • Study of Colchicine Treatment to Slow Down Aortic Valve Stenosis Progression in Adult Patients with Moderate Disease

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Aortic valve disease
    • Aortic valve stenosis
    • Inflammation
    Investigated Drugs:
    • Colchicine
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!